Sign Up Today and Learn More About Augury Stock
Invest in or calculate the value of your shares in Augury or other pre-IPO companies through EquityZen's platform.
Augury Stock (AUGU)
Augury provides machine health diagnostics designed to help reduce downtime and increase supply chain resilience.
About Augury Stock
Founded
2011
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
Augury helps eliminate downtime, reduce maintenance costs and maximize productivity for critical machines in industrial and commercial applications ranging from bottling and food processing to paper products and pharmaceuticals. Its Machine Health solutions combine advanced sensors with powerful AI capabilities and collaboration tools to help teams understand when machines are at risk.
Augury Press Mentions
Stay in the know about the latest news on Augury
Augury and MaintainX Partner to Deliver Closed-Loop Maintenance Execution for Frontline Teams
prnewswire • Mar 24, 2026
Augury Names New Product and Engineering Leadership to Accelerate Progress in Industrial AI
prnewswire • Mar 10, 2026
Global Internet-of-Things Leaders Recognized in 10th Annual IoT Breakthrough Awards Program
globenewswire • Jan 07, 2026
Munich Re Ventures shuts down $1.2B venture arm, pivots innovation strategy in-house — TFN
techfundingnews • Nov 10, 2025
Munich Re winds down $1.2bn VC arm after decade of investing
globalventuring • Oct 29, 2025
Augury Management
Leadership team at Augury
Co-Founder, CEO
Saar Yoskovitz
Co-Founder and CTO
Gal Shaul
Join now and verify your accreditation status to gain access to:
- Augury Current Valuation
- Augury Stock Price
- Augury Management
- Available deals in Augury and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Augury Cap Table and Funding History by Share Class and Liquidity Preferences
- Augury Revenue and Financials
- Augury Highlights
- Augury Business Model
- Augury Risk Factors
- Augury Research Report from SACRA Research
Trading Augury Stock
How to invest in Augury stock?
Accredited investors can buy pre-IPO stock in companies like Augury through EquityZen funds. These investments are made available by existing Augury shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Augury stock?
Shareholders can sell their Augury stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
